期刊文献+

IMMUNITE1000化学发光分析系统检测白细胞介素-6的性能验证 被引量:1

Method performance verification of the detection of interleukin-6by using IMMUNITE1000chemiluminescence detection system
下载PDF
导出
摘要 目的验证IMMUNITE1000化学发光仪分析系统定量检测白细胞介素-6(IL-6)的性能。方法按国际标准化组织(ISO)15189实验室认可的要求,收集血清标本进行IL-6检测,验证IMMUNITE1000化学发光仪分析系统定量检测IL-6的精密度、准确度、线性范围、临床可报告范围及正常参考区间,评估其检验效能。结果高值与低值标本的日间变异系数(CV)分别为6.42%、1.97%,批内CV分别为3.40%、3.82%;标准品检测值相对偏倚(bias%)为0.91%;回归方程:Y=0.986 X-7.1(r2=0.999,P〈0.05);稀释至27倍,回收率在97%~100%之间,临床可报告范围为2~27 000pg/mL;95%参考区间为0~5.3pg/mL。结论该系统检测性能符合厂家声明,满足临床实验室质量要求。 Objective To verify the performance of quantitative detection of interleukin-6 by using IMMUNITE1000 chemilumi-nescence analyzer.Methods According to the requirements of International Organization for Standardization(ISO)1 5 189,serum specimen were collected and levels of IL-6 were detected.The precision,accuracy,analytical measurement range,reportable range amd normal reference range of quantitative detection of interleukin-6 by using IMMUNITE1000 chemiluminescence analyzer were verified,and its performance was evaluated.Results The coefficient variation(CV)of between-day precision of high and low value was 6.42% and 1.97% respectively,and that of within-run precision was 3.40% and 3.82% respectively.Compared the test re-sults with the target values,the bias % was 0.91%.The regression equation:Y =0.986X - 7.1 (r 2 = 0.999,P 〈 0.05 ).With 27 times diluted,the recovery rate was from 97% to 100%,and the clinical reportable range was 2 to 27 000 pg/mL.The 95% refer-ence interval ranged from 0 to 5.3 pg/mL.Conclusion The performance of this system meets the manufacturer′s declaration,and could satisfy the quality requirements of clinical laboratory.
出处 《国际检验医学杂志》 CAS 2015年第13期1858-1860,共3页 International Journal of Laboratory Medicine
关键词 白细胞介素-6 化学发光 性能验证 chemiluminescence performance verification
  • 相关文献

参考文献8

二级参考文献56

  • 1陈文祥,申子瑜,杨振华.临床检验分析质量指标的设定[J].中华检验医学杂志,2006,29(4):298-300. 被引量:51
  • 2Department of Health and Human Services,Centers for Medicare & Medicaid Services.Clinical laboratory improvement amendments of 1988:final rule.Fed Register,2003:3704.
  • 3NCCLS.EP10-A Preliminary evaluation of quantitative clinical laboratory methods.Wayne PA:National Committee for Clinical Laboratory Standards,1998.
  • 4Spencer CA.Thyroid profiling for the 1990s:free T4 estimate or sensitive TSH measurement.J Clin Immunoassay,1989,12:82-89.
  • 5NCCLS.EP6-P2 Evaluation of linearity of quantitative analytical methods.Proposed guideline-second edition,2002.21-20.
  • 6NCCLS.C28-A2 How to define and determine reference intervals in the clinical laboratory; approved guideline.Wayne PA:NCCLS,2000.
  • 7NCCLS.EP9-A Method comparison and bias estimation using patient samples.Wayne PA:National Committee for Clinical Laboratory Standards,1995.
  • 8Petersen HP, Fraser CG, Kallner A, et al. Introduction: strategies to set global quality specifications in laboratory medicine. Scand J Clin Lab Invest, 1999,59:477-478.
  • 9Fraser CG, Petersen HP, Ricos C, et al. Proposed quality specifications for the imprecision and inaccuracy of analytical systems in clinical chemistry. Eur J Clin Chem Clin Biochem, 1992,30:311-317.
  • 10Thienpont L,Franzini C, Kratochvila J, et al. Analytical quality specifications for reference methods and operating specifications for networks of reference laboratories. Eur J Clin Chem Clin Biochem, 1995,33:949-957.

共引文献253

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部